Atlas Trials

Abramson Cancer Center at Penn Medicine

454 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Abramson Cancer Center at Penn Medicine

RecordFirmDate
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT) (NCT01004718)Abramson Cancer Center at Penn Medicine2009-05-01
Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma (NCT00948935)Abramson Cancer Center at Penn Medicine2009-04-01
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma (NCT01020292)Abramson Cancer Center at Penn Medicine2009-04-01
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme (NCT00915694)Abramson Cancer Center at Penn Medicine2009-04-01
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer (NCT01026337)Abramson Cancer Center at Penn Medicine2009-04-01
Visualization of the Effect of Acupuncture on Brain Serotonin in Breast Cancer Survivors (NCT01018108)Abramson Cancer Center at Penn Medicine2009-03-01
Fluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and Larynx (NCT01020097)Abramson Cancer Center at Penn Medicine2009-03-01
Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer (NCT01018251)Abramson Cancer Center at Penn Medicine2009-03-01
Intrapleural Gene Transfer for Pleural Mesothelioma (NCT01212367)Abramson Cancer Center at Penn Medicine2009-02-01
Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment (NCT01018901)Abramson Cancer Center at Penn Medicine2009-01-01
Acupuncture and Gabapentin for Hot Flashes Among Breast Cancer Survivors (NCT01005108)Abramson Cancer Center at Penn Medicine2009-01-01
The Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) Registry (NCT02346435)Abramson Cancer Center at Penn Medicine2009-01-01
Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors (NCT00978081)Abramson Cancer Center at Penn Medicine2009-01-01
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer (NCT00892515)Abramson Cancer Center at Penn Medicine2008-10-01
Hydroxychloroquine and Temsirolimus in Treating Patients With Metastatic Solid Tumors That Have Not Responded to Treatment (NCT00909831)Abramson Cancer Center at Penn Medicine2008-10-01
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer (NCT00984074)Abramson Cancer Center at Penn Medicine2008-10-01
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas (NCT00783367)Abramson Cancer Center at Penn Medicine2008-07-01
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00714181)Abramson Cancer Center at Penn Medicine2008-06-01
The Radiation Oncology Registry and Biosample Repository (NCT01577251)Abramson Cancer Center at Penn Medicine2008-06-01
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer (NCT00717587)Abramson Cancer Center at Penn Medicine2008-06-01
Fluorine F 18 EF5 PET/CT Imaging in Patients With Locally Advanced or Recurrent/Metastatic Cervical Cancer (NCT00978874)Abramson Cancer Center at Penn Medicine2008-05-01
Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation Therapy (NCT00955942)Abramson Cancer Center at Penn Medicine2007-12-01
A Phase I Clinical Trial of Autologous Dendritic Cell Vaccine for Recurrent Ovarian or Primary Peritoneal Cancer (NCT00683241)Abramson Cancer Center at Penn Medicine2007-11-01
HPPH and PDT for Pleural Malignancy (NCT01673074)Abramson Cancer Center at Penn Medicine2007-11-01
Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC (NCT00647426)Abramson Cancer Center at Penn Medicine2007-11-01
Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy (NCT00589420)Abramson Cancer Center at Penn Medicine2007-07-27
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias (NCT00780104)Abramson Cancer Center at Penn Medicine2007-07-01
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery (NCT00589056)Abramson Cancer Center at Penn Medicine2007-06-01
Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer (NCT00472693)Abramson Cancer Center at Penn Medicine2007-05-01
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation (NCT00374933)Abramson Cancer Center at Penn Medicine2007-04-01
Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer (NCT00602602)Abramson Cancer Center at Penn Medicine2007-03-01
Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies (NCT00776373)Abramson Cancer Center at Penn Medicine2007-01-01
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer (NCT00602329)Abramson Cancer Center at Penn Medicine2006-02-01
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma (NCT00353457)Abramson Cancer Center at Penn Medicine2006-02-01
Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme (NCT00128635)Abramson Cancer Center at Penn Medicine2005-10-01
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors (NCT02157831)Abramson Cancer Center at Penn Medicine2005-07-01
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer (NCT00599989)Abramson Cancer Center at Penn Medicine2005-01-01
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast (NCT00107211)Abramson Cancer Center at Penn Medicine2005-01-01
Temozolomide and Sorafenib in Treating Patients With Metastatic or Unresectable Melanoma (NCT00602576)Abramson Cancer Center at Penn Medicine2005-01-01
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura (NCT00601848)Abramson Cancer Center at Penn Medicine2004-11-01
Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer (NCT00079157)Abramson Cancer Center at Penn Medicine2004-02-01
Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer (NCT00077519)Abramson Cancer Center at Penn Medicine2004-01-01
Phase 1, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors (NCT02225002)Abramson Cancer Center at Penn Medicine2004-01-01
Study of Bexarotene in Patients With Acute Myeloid Leukemia (NCT00316030)Abramson Cancer Center at Penn Medicine2004-01-01
Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions (NCT00066404)Abramson Cancer Center at Penn Medicine2003-04-01
Study of Temzolomide and Gleevec in Advanced Melanoma (NCT00667953)Abramson Cancer Center at Penn Medicine2003-01-01
Infusional C-myb ASODN in Advanced Hematologic Malignancies (NCT00780052)Abramson Cancer Center at Penn Medicine2002-09-01
Tipifarnib Plus Radiation Therapy After Combination Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer (NCT00025480)Abramson Cancer Center at Penn Medicine2001-08-01
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer (NCT00003736)Abramson Cancer Center at Penn Medicine1999-06-01
Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer (NCT00003777)Abramson Cancer Center at Penn Medicine1998-12-01
MRI to Detect Breast Tumors in Women (NCT00003302)Abramson Cancer Center at Penn Medicine1998-05-01
Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors (NCT00002902)Abramson Cancer Center at Penn Medicine1997-04-01
Gene Therapy in Treating Patients With Primary Brain Tumors (NCT00002824)Abramson Cancer Center at Penn Medicine1996-02-01
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia (NCT00002592)Abramson Cancer Center at Penn Medicine1993-06-01
← Previous

Track Abramson Cancer Center at Penn Medicine automatically

Every clearance here is in the API, with alerts when new ones post.